Preliminary study of a traditional Chinese medicine formula in systemic lupus erythematosus patients to taper steroid dose and prevent disease flare-up

Preliminary study of a traditional Chinese medicine formula in systemic lupus erythematosus patients to taper steroid dose and prevent disease flare-up

Systemic lupus erythematosus (SLE) is a chronic systemic autoimmune disease. Prolonged complete remission is rare. Most patients with SLE need long-term treatment with glucocorticoid and immunomodulators. However, side effects because of the above medications are common. We evaluated the effect of a...

Full description

Bibliographic Details
Main Authors:	Yen-Nung Liao, Ching-Shen Liu, Tong-Rong Tsai, Yu-Chiang Hung, Shun-Jen Chang, Hong-Long Lin, Ying-Chou Chen, Han-Ming Lai, Shan-Fu Yu, Chung-Jen Chen
Format:	Article
Language:	English
Published:	Wiley 2011-07-01
Series:	Kaohsiung Journal of Medical Sciences
Subjects:	Anti-dsDNA Complementary and alternative medicine Steroid Systemic lupus erythematosus Traditional Chinese medicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S1607551X11000751

Similar Items

Autoantibodies to dsDNA in the diagnosis, classification and follow-up of patients with systemic lupus erythematosus
by: Jan Damoiseaux, et al.
Published: (2023-01-01)

Comparative analysis of contemporary anti-double stranded DNA antibody assays for systemic lupus erythematosus
by: Claus-Juergen Bauer, et al.
Published: (2023-12-01)

Systemic Lupus Erythematosus: Definitions, Contexts, Conflicts, Enigmas
by: Ole Petter Rekvig
Published: (2018-03-01)

Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus
by: Maria Infantino, et al.
Published: (2022-01-01)

Risk factors for subsequent lupus nephritis in patients with juvenile-onset systemic lupus erythematosus: a retrospective cohort study
by: Tzu-Chuan Hsu, et al.
Published: (2023-03-01)

Association of urine autoantibodies with disease activity in systemic lupus erythematosus
by: Yuxian Zhang, et al.
Published: (2024-01-01)

CCR6+ Th cell distribution differentiates systemic lupus erythematosus patients based on anti-dsDNA antibody status
by: Wei Zhong, et al.
Published: (2018-02-01)

Safety and efficacy of belimumab after B cell depletion therapy in systemic LUPUS erythematosus (BEAT-LUPUS) trial: statistical analysis plan
by: Patrick Muller, et al.
Published: (2020-07-01)

Comparisons of Anti-dsDNA Antibody Detection Methods by Chemiluminescent Immunoassay and Enzyme-Linked Immunosorbent Assay in Systemic Lupus Erythematosus
by: Huang-Chen Chang, et al.
Published: (2021-10-01)

Comparison of urinary parameters, biomarkers, and outcome of childhood systemic lupus erythematosus early onset-lupus nephritis
by: Daniele Faria Miguel, et al.
Published: (2020-02-01)

Clinical significance of antinucleosome antibodies in patients with “early” systemic lupus erythematosus
by: M. A. Kotovskaya, et al.
Published: (2016-05-01)

Fucosylation of anti-dsDNA IgG1 correlates with disease activity of treatment-naïve systemic lupus erythematosus patients
by: Jing Han, et al.
Published: (2022-03-01)

Estudo longitudinal do anticorpo antilipoproteína lipase e sua relação com atividade de doença nos indivíduos com lúpus eritematoso sistêmico sem anticorpos anti-dsDNA Longitudinal fluctuation of anti-lipoprotein lipase antibody is related with disease activity in systemic lupus erythematosus patients without anti-dsDNA antibodies
by: Jozélio Freire de Carvalho, et al.
Published: (2009-02-01)

Anti-DFS70 antibodies in systemic lupus erythematosus: Prevalence in a large Chinese cohort and an unexpected association with anti-dsDNA antibodies by a long-term follow-up
by: Yingxin Dai, et al.
Published: (2022-09-01)

Pulmonary Manifestations of Systemic Lupus Erythematosus Among Adults in Aseer Region, Saudi Arabia
by: Alhammadi NA, et al.
Published: (2024-03-01)

Identificación de predictores serológicos de recaída en pacientes con lupus eritematoso sistémico: estudio prospectivo de 12 meses
by: Elena Kokuina, et al.

Discoid lupus erythematosus
by: Anilkumar L Bhoweer, et al.
Published: (2018-01-01)

Anti-dsDNA, anti-nucleosome and anti-C1q antibodies as disease activity markers in patients with systemic lupus erythematosus
by: Živković Valentina, et al.
Published: (2014-01-01)

Association between the Duration of Steroid Therapy with Hyperglycemia in Patients with Systemic Lupus Erythematosus (SLE)
by: Farahdiva Audrey Widyanrika, et al.
Published: (2024-01-01)

Allogeneic cord blood regulatory T cells decrease dsDNA antibody and improve albuminuria in systemic lupus erythematosus
by: Mi-Ae Lyu, et al.
Published: (2023-09-01)

Lupus erythematosus panniculitis in pregnancy
by: Swati Gondane, et al.
Published: (2015-01-01)

Increased binding of anti-dsDNA antibodies to short oligonucleotides modified with topoisomerase I reveals a potential new enzyme function independent from DNA relaxation
by: Manuela Frese-Schaper, et al.
Published: (2023-10-01)

The correlation between the levels of anti-dsDNA IgA antibody and the severity of systemic lupus erythematosus based on cutaneous vasculitis
by: H.P. Faridin, et al.
Published: (2022-07-01)

Serum IgE anti-dsDNA autoantibodies in patients with proliferative lupus nephritis are associated with tubulointerstitial inflammation
by: Leran Chen, et al.
Published: (2023-12-01)

Impact of systemic steroids combined with immunosuppressive treatment on glaucomatous features in patients with systemic lupus erythematosus
by: Marta P. Wiacek, et al.
Published: (2022-01-01)

cGAS deficiency enhances inflammasome activation in macrophages and inflammatory pathology in pristane-induced lupus
by: Sarinya Kumpunya, et al.
Published: (2022-12-01)

Association of Clinical Manifestations of Systemic Lupus Erythematosus and Complementary Therapy Use in Taiwanese Female Patients: A Cross-Sectional Study
by: Ming-Chi Lu, et al.
Published: (2022-07-01)

The dsDNA, Anti-dsDNA Antibody, and Lupus Nephritis: What We Agree on, What Must Be Done, and What the Best Strategy Forward Could Be
by: Ole Petter Rekvig
Published: (2019-05-01)

Clinical, Demographic and Laboratory Information of Patients with SLE in Ardabil Province (Original article)
by: Yousef Mohammadi-Kebar, et al.
Published: (2023-12-01)

Anti- nucleosome antibodies- a valuable test in systemic iupus erythematosus
by: Ahmed A. Abid, et al.
Published: (2011-04-01)

Lupus Enteritis: An Uncommon Manifestation of Systemic Lupus Erythematosus as an Initial Presentation
by: Vishal Bodh, et al.
Published: (2017-07-01)

Lack of patient education is risk factor of disease flare in patients with systemic lupus erythematosus in China
by: Le Zhang, et al.
Published: (2019-06-01)

Immune Phenotype as a Biomarker for Systemic Lupus Erythematosus
by: Shingo Nakayamada, et al.
Published: (2023-06-01)

Update and clinical management of anti-DNA auto-antibodies
by: González Rodríguez Concepción, et al.
Published: (2021-04-01)

Anti-dsDNA B-Cell ELISpot as a Monitoring and Flare Prediction Tool in SLE Patients
by: Albert Pérez-Isidro, et al.
Published: (2023-02-01)

Lupus Nephritis: Enigmas, Conflicting Models and an Emerging Concept
by: Natalya Seredkina, et al.
Published: (2013-06-01)

A teen with blaschkolinear tumid lupus erythematosus
by: Amy Shen, BS, et al.
Published: (2022-03-01)

Linear cutaneous lupus erythematosus following the lines of Blaschko - Case report
by: Ayana Karla de Oliveira Ferreira Marinho, et al.
Published: (2016-08-01)

Successful treatment with oral steroid and hydroxychloroquine in a patient with systemic lupus erythematosus upon COVID‐19 infection: A case report with detailed laboratory data
by: Makoto Kondo, et al.
Published: (2021-08-01)

Cutaneous Toll-like Receptor 9 Pre-Defines Hydroxychloroquine Dosage in Patients with Both Discoid and Subacute Lupus Erythematosus
by: Karolina A. Englert, et al.
Published: (2023-11-01)